These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 5011390)

  • 1. Renal resistance to parathyroid hormone with osteitis fibrosa: "pseudohypohyperparathyroidism".
    Frame B; Hanson CA; Frost HM; Block M; Arnstein AR
    Am J Med; 1972 Mar; 52(3):311-21. PubMed ID: 5011390
    [No Abstract]   [Full Text] [Related]  

  • 2. Renal-nonresponsive, bone-responsive pseudohypoparathyroidism. A case with normal vitamin D metabolite levels and clinical features of rickets.
    Dabbagh S; Chesney RW; Langer LO; DeLuca HF; Gilbert EF; DeWeerd JH
    Am J Dis Child; 1984 Nov; 138(11):1030-3. PubMed ID: 6548601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudohypoparathyroidism with raised plasma alkaline phosphatase.
    Cohen RD; Vince FP
    Arch Dis Child; 1969 Feb; 44(233):96-101. PubMed ID: 5304559
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasma parathormone, calcium and phosphorus in patients with renal osteodystrophy undergoing chronic hemodialysis.
    Genuth SM; Sherwood LM; Vertes V; Leonards JR
    J Clin Endocrinol Metab; 1970 Jan; 30(1):138-40. PubMed ID: 5409532
    [No Abstract]   [Full Text] [Related]  

  • 5. Bone disease and chronic renal failure.
    Bourke E
    Ir J Med Sci; 1974 Jul; 0(0):suppl:72-4. PubMed ID: 4604173
    [No Abstract]   [Full Text] [Related]  

  • 6. Renal resistance to parathyroid hormone with hyperphosphatemic osteomalacia and osteitis fibrosa. A case report.
    Milgram JW; Engh CA; Hamilton CR; Kammer GM
    J Bone Joint Surg Am; 1974 Oct; 56(7):1493-500. PubMed ID: 4433369
    [No Abstract]   [Full Text] [Related]  

  • 7. Caclium, phosphorus, and bone in renal disease and transplantation.
    Bricker NS; Slatopolsky E; Reiss E; Avioli LV
    Arch Intern Med; 1969 May; 123(5):543-53. PubMed ID: 4888973
    [No Abstract]   [Full Text] [Related]  

  • 8. Limitation by hyperphosphataemia of the "prophylactic" use of vitamin D metabolites in the treatment of osteitis fibrosa in patients on chronic haemodialysis.
    de Fremont JF; Sebert JL; Gueris J; Marie P; Coevoet B; Makdassi R; Lambrey G; Meunier P; Fournier A
    Proc Eur Dial Transplant Assoc; 1979; 16():675-6. PubMed ID: 232918
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pseudohypohyperparathyroidism or Frame's pseudohypoparathyroidism type I].
    Malpuech G; Gaillard G; Merle P; Pailloncy JM; Raynaud EJ
    Arch Fr Pediatr; 1975 Mar; 32(3):235-45. PubMed ID: 178286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypo-hyperparathyroidism due to renal resistance to parathyroid hormones.
    Ebrahimi MA; Nik-Akhtar B
    Br J Clin Pract; 1979 Jul; 33(7):209-14. PubMed ID: 526426
    [No Abstract]   [Full Text] [Related]  

  • 11. [A case of pseudohypoparathyroidism with osteitis fibrosa cystica].
    Scandola A; Villa MP; Lucchi A; Mazzanti L; Turchi S
    Minerva Pediatr; 1977 Nov; 29(34):2047-51. PubMed ID: 593239
    [No Abstract]   [Full Text] [Related]  

  • 12. Neonatal pseudohypoparathyroidism.
    Narang M; Salota R; Sachdev SS
    Indian J Pediatr; 2006 Jan; 73(1):97-8. PubMed ID: 16444071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure.
    Andress DL; Norris KC; Coburn JW; Slatopolsky EA; Sherrard DJ
    N Engl J Med; 1989 Aug; 321(5):274-9. PubMed ID: 2631697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic bone disease in pseudohypoparathyroidism: radiologic features.
    Burnstein MI; Kottamasu SR; Pettifor JM; Sochett E; Ellis BI; Frame B
    Radiology; 1985 May; 155(2):351-6. PubMed ID: 3983385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D metabolism during recovery from severe osteitis fibrosa cystica of primary hyperparathyroidism.
    Gonzalez-Villapando C; Porath A; Berelowitz M; Marshall L; Favus MJ
    J Clin Endocrinol Metab; 1980 Nov; 51(5):1180-3. PubMed ID: 6893459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parathyroid hormone response to hypocalcemia in hemodialysis patients with osteomalacia.
    Andress D; Felsenfeld AJ; Voigts A; Llach F
    Kidney Int; 1983 Sep; 24(3):364-70. PubMed ID: 6645210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal-resistant hormonoplethoric hypoparathyroidism with evidence for a defective response to cAMP.
    Duck SC; Rosenberg EM; Ratzan SK; Haymond MW
    J Clin Endocrinol Metab; 1978 Sep; 47(3):640-6. PubMed ID: 233678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful medical management of osteitis fibrosa due to "tertiary" hyperparathyroidism.
    Vosik WM; Anderson CF; Steffee WP; Johnson WJ; Arnaud CD; Goldsmith RS
    Mayo Clin Proc; 1972 Feb; 47(2):110-3. PubMed ID: 5010725
    [No Abstract]   [Full Text] [Related]  

  • 19. Osteitis fibrosa cystica with renal parathyroid hormone resistance: a review of pseudohypoparathyroidism with insight into calcium homeostasis.
    Eubanks PJ; Stabile BE
    Arch Surg; 1998 Jun; 133(6):673-6. PubMed ID: 9637471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Regression of renal ostitis fibrosa through permanent dialysis].
    Ritz E; Franz HE; Kuhn HM; Jahns E; Schenck P
    Klin Wochenschr; 1968 Dec; 46(23):1249-53. PubMed ID: 5714775
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.